How to tell the difference between normal/abnormal biomarkers; Knome aids Parkinson's discovery

> It is difficult to distinguish the difference between biomarkers that indicate disease and those that occur when everything is normal. New research sheds light on how to tell the difference. NPL release

> Cambridge, MA-based genomics company Knome says its technology helped in the discovery of a Parkinson's biomarker. Report

> Researchers find a two-for-one gene that could cause both Alzheimer's and Type 2 diabetes. Mount Sinai release

> Biomarkers may predict the likelihood of miscarriage, according to a British researcher. Article

> Researchers at Oxford University are seeking female volunteers to participate in a research study looking at potential markers in endometriosis. More information

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.